STANOZIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Stanozide, and what generic alternatives are available?
Stanozide is a drug marketed by Everylife and is included in one NDA.
The generic ingredient in STANOZIDE is isoniazid. There are five drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the isoniazid profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Stanozide
A generic version of STANOZIDE was approved as isoniazid by OMNIVIUM PHARMS on June 26th, 1997.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for STANOZIDE?
- What are the global sales for STANOZIDE?
- What is Average Wholesale Price for STANOZIDE?
Summary for STANOZIDE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 154 |
| Patent Applications: | 2,949 |
| DailyMed Link: | STANOZIDE at DailyMed |
US Patents and Regulatory Information for STANOZIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Everylife | STANOZIDE | isoniazid | TABLET;ORAL | 080126-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Everylife | STANOZIDE | isoniazid | TABLET;ORAL | 080126-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
